I’ve been reflecting on how critical it is for us to stay vigilant about adverse event reporting in clinical trials. Recently, I came across data indicating that nearly 30% of reported adverse events go unaddressed, which raises serious safety concerns. How is everyone else approaching risk management in their studies?